FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

421924006: Rotigotine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2006. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2615490013 Rotigotine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2618159018 Rotigotine en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rotigotine Is a Aralkylamine true Inferred relationship Existential restriction modifier
Rotigotine Is a Substance with dopamine receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Rotigotine Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier
Rotigotine Is a Antiparkinsonian agent true Inferred relationship Existential restriction modifier
Rotigotine Is a Drug allergen false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing rotigotine Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Rotigotine 4mg/24hours transdermal patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours transdermal patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours transdermal patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Product containing rotigotine in transdermal dose form (medicinal product form) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has basis of strength substance True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has precise active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch Has basis of strength substance True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch Has precise active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch Has basis of strength substance True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch Has precise active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Rotigotine Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing only rotigotine in transdermal dose form (medicinal product form) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 125 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has precise active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 125 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has basis of strength substance True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 41.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has precise active ingredient True Rotigotine Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 41.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has basis of strength substance True Rotigotine Inferred relationship Existential restriction modifier 1
Neupro 8mg/24hours transdermal patches (Ethigen Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Ethigen Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Ethigen Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Ethigen Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (CST Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (CST Pharma Ltd) 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (CST Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (CST Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (CST Pharma Ltd) 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (CST Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Schwarz Pharma Ltd) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours patches Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours patches 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours patches 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (DE Pharmaceuticals) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (DE Pharmaceuticals) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (DE Pharmaceuticals) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (DE Pharmaceuticals) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours transdermal patch Has specific active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours patches 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Schwarz Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours patches 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours transdermal patch Has specific active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours transdermal patch Has specific active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches 7 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Generic Neupro transdermal patches starter pack Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Neupro transdermal patches starter pack (Schwarz Pharma Ltd) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 3mg/24hours transdermal patches (UCB Pharma Ltd) Has active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 3mg/24hours transdermal patches (UCB Pharma Ltd) Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Neupro 3mg/24hours transdermal patches (UCB Pharma Ltd) 28 patch Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 1mg/24hours transdermal patches Has active ingredient False Rotigotine Inferred relationship Existential restriction modifier
Rotigotine 1mg/24hours transdermal patches Has specific active ingredient True Rotigotine Inferred relationship Existential restriction modifier

Page 1 of 2 End


This concept is not in any reference sets

Back to Start